Health News

In her latest piece on the New York Times’ “Opinionator” blog, author and journalist Tina Rosenberg argues that the terms of Gilead’s recent agreement with the Medicines Patent Pool is “confirmation of a dangerous new trend: middle-income countries as a target market for drug makers.”

Read more

Filed under: Pharmacy News
Tags: AIDS, Drug, medicine, Pharmacy

Related posts

• U-M scientists identify new reservoir for hidden HIV-infected cells that can serve as factory for new infections (0)
  University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for [...]
  
  
• Swaziland’s supply of antiretroviral drugs running low (0)
  "Cash-strapped Swaziland's state hospitals have only two months' supplies of AIDS drugs, the country's health minister has told parliament in an assessment that AIDS patients and activists took as a death sentence," the Associated Press/Seattle Times reports. More than 60,000 Swazis receive antiretroviral medicine at no cost from state-run hospitals. Read more [tags] Pharmacy News [/tags]
  
  
• Pros and cons of HIV treatments in developing countries (0)
  Palumbo is co-leading a clinical study of anti-HIV medicines in Africa and India for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT). The randomized trial found that a cohort of 82 HIV-infected children ages 6 to 35 months responded better to treatment with the protease-inhibiting drug lopinavir (LPV/r) than did a cohort of [...]
  
  
• IPS examines subsidized malaria drugs in Kenya (0)
  Inter Press Service looks at the roll out of the Affordable Medicines Facility-malaria in Kenya. The program, which is managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria, makes subsidized malaria medications available through private pharmacies in seven other pilot countries - Cambodia, Ghana, Madagascar, Niger, Nigeria, Tanzania and Uganda. Read more [tags] Pharmacy News [...]
  
  
• India Rejects Patents For Two Key AIDS Drugs (0)
  The Indian Patent Office has just rejected patent applications related to two AIDS medicines - lopinavir/ritonavir and atazanavir - on the basis that they did not merit patents under India's patents law... Read more [tags] Pharmacy News [/tags]